Richard Anthony Cunningham,'s Net Worth
-$7.93 Thousand
Who is Richard Anthony Cunningham,?
Richard Anthony Cunningham, does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TYME TECHNOLOGIES, INC., Caldera Pharmaceuticals Inc, and Anebulo Pharmaceuticals, Inc..
SEC CIK
Richard Anthony Cunningham,'s CIK is 0001624783
Past Insider Trading and Trends
2017 was Richard Anthony Cunningham,'s most active year for acquiring shares with 3 total transactions. Richard Anthony Cunningham,'s most active month to acquire stocks was the month of March. 2022 was Richard Anthony Cunningham,'s most active year for disposing of shares, totalling 3 transactions. Richard Anthony Cunningham,'s most active month to dispose stocks was the month of August. 2017 saw Richard Anthony Cunningham, paying a total of $8,035.50 for 46,785 shares, this is the most they've acquired in one year. In 2022 Richard Anthony Cunningham, cashed out on 3,826,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TYME TECHNOLOGIES, INC. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Caldera Pharmaceuticals Inc No price found
Chief Executive OfficerRichard Anthony Cunningham, owns 21,428 units of Common Stock, $0.001 par value.acquired a total of 21,428 shares in Caldera Pharmaceuticals Inc at a cost of $7,928.36.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 4
|
∞
| 21.43K |
$0.37 | $7,928.36 | 21.43K |
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Anebulo Pharmaceuticals, Inc. (ANEB) Snapshot price: $2.38
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |